Ashwagandha KSM-66 vs Sensoril: What’s the Difference?

KSM-66 is a branded ashwagandha extract. In manufacturer and retailer materials it is described as a full-spectrum extract obtained from the root of Withania somnifera, produced through a process intended to retain a profile of the root’s constituents. On a Supplement Facts panel, “KSM-66” identifies a specific branded ingredient — an attributed disclosure fact, not a quality verdict.

The FDA’s Dietary Supplement Labeling Guide describes the convention that the Supplement Facts panel identifies the ingredient and declares the amount per serving. (FDA Dietary Supplement Labeling Guide) Where a label names KSM-66, the named extract and the declared amount are the comparable facts. A branded name describes how the ingredient is presented and characterized; it does not, by itself, establish dose, quality, suitability, or any health outcome.

This article does not invent KSM-66 specifications beyond what is documented on labels and in manufacturer materials, and it does not treat KSM-66 as universally superior to any other ashwagandha preparation.

Sensoril is another branded ashwagandha extract. In manufacturer and retailer materials it is described as a standardized extract derived from the root and leaf of Withania somnifera. Like KSM-66, it is a specific branded ingredient that may appear on a Supplement Facts panel as an attributed disclosure fact.

Because Sensoril is described as using a different plant-part basis than KSM-66, it is a different preparation, not a different name for the same extract. A label that names Sensoril is disclosing a specific branded ingredient with its own documented specification — recorded as stated, never silently upgraded into a quality or effectiveness ranking.

This article does not invent Sensoril specifications beyond what is documented on labels and in manufacturer materials, and it does not treat Sensoril as universally superior to any other ashwagandha preparation.

The most commonly cited difference between KSM-66 and Sensoril is the plant part each extract is derived from. KSM-66 is described as a root-only extract; Sensoril is described as an extract derived from root and leaf. Withania somnifera root and leaf can carry different constituent profiles, so an extract specification that includes leaf is not simply a “stronger” or “weaker” version of a root-only extract — it is a different preparation.

This is why the plant part is a label field worth checking in its own right. Two products can both say “ashwagandha extract” and use extracts derived from different plant parts, standardized to different markers, at different declared amounts. The honest comparison treats the plant part as a formulation attribute to compare, not as a quality verdict.

This article does not invent constituent comparisons between root and leaf, does not claim that one plant-part basis is inherently better, and does not convert a plant-part disclosure into an effectiveness claim. Where a product discloses a plant part, record it as an attributed disclosure fact.

“Ashwagandha” on a label is an ingredient name, not a complete specification. Two ashwagandha products can differ in every respect that affects comparison: whether the ingredient is root powder or an extract, which branded extract is used, which plant part the extract is derived from, any stated withanolide standardization, the declared amount per serving, the serving size, and the documented testing. The NIH Office of Dietary Supplements and the NCCIH provide general, non-therapeutic context on dietary supplements and ashwagandha. (NIH ODS) · (NCCIH)

Extract specification matters because it determines what two products are actually being compared. A KSM-66 product and a Sensoril product are not interchangeable just because both say “ashwagandha.” Reading the named extract, the plant part, and any standardization is what makes the comparison honest — and what prevents a larger milligram number or a brand name from standing in for a real comparison.

Withanolides are a group of naturally occurring compounds in Withania somnifera commonly used as a marker for characterizing extracts. Where a label states a withanolide percentage or other standardization, that is an attributed disclosure fact to compare. This article does not invent withanolide percentages, does not treat a higher percentage as automatically better, and does not convert a standardization statement into a potency or effectiveness claim.

A number of human trials have examined ashwagandha in relation to self-reported stress, measures of sleep, markers such as cortisol, and other outcomes. Some studies report changes in certain measures in certain groups, while others report mixed or limited findings. The published research includes studies on specific branded extracts as well as studies on ashwagandha more generally. (NCBI / PubMed — ashwagandha)

• Preparation-specific findings. Where a study reports results for a specific extract (for example KSM-66 or Sensoril) at a specific dose and duration in a specific population, those findings describe that preparation in that study. They are not automatically generalizable to every ashwagandha product.
• Marker changes are not outcomes. A change in a marker such as cortisol is not the same as a demonstrated treatment effect, and any marker change is not a universal or guaranteed outcome.
• Small samples and short durations. Many ashwagandha trials are small and relatively short. Their results describe the studied group and period, not every person or every product.
• Preclinical evidence is hypothesis-generating. Laboratory and animal studies on withanolides and related compounds are not established human health benefits and should not be read as proof of an effect in people.

This article does not claim that KSM-66 or Sensoril treats, prevents, or cures anxiety, depression, insomnia, infertility, thyroid disease, diabetes, cancer, or any other condition. It does not promise testosterone, fertility, sleep, athletic-performance, or stress outcomes beyond what cited evidence actually supports, and it does not present “adaptogen,” “stress support,” “cortisol balance,” or “sleep support” as established, independently defined health outcomes.

To separate attributed claims from documented support, use the Evidence Checker.

The single most important habit when comparing KSM-66 and Sensoril is to keep three levels of evidence separate:

• Evidence about a specific preparation — findings reported for KSM-66, or for Sensoril, in a specific study.
• Evidence about ashwagandha generally — findings reported across preparations, often without naming a specific branded extract.
• Preclinical and mechanistic evidence — laboratory and animal findings that generate hypotheses but do not establish human outcomes.

These are not interchangeable. A result reported for KSM-66 does not automatically apply to Sensoril, to root powder, or to ashwagandha generally. A result reported for ashwagandha generally does not automatically apply to a specific branded extract. And a laboratory or animal finding does not automatically become a human health benefit.

This is why this article does not rank KSM-66 above Sensoril (or vice versa), does not treat a branded name as proof of superiority, and does not promise that any preparation produces stress, sleep, testosterone, fertility, or athletic-performance outcomes. The honest comparison combines the declared extract, the declared plant part, the declared amount, the documented testing, and the separate question of what preparation-specific evidence actually shows.

Whether a product uses KSM-66, Sensoril, another branded extract, or an unbranded ashwagandha extract, work through the Supplement Facts panel field by field:

• Extract name — whether the label names “KSM-66,” “Sensoril,” another branded extract, or only “ashwagandha extract.” Where a branded extract is named, that is an attributed disclosure fact to compare. A brand name describes how the ingredient is presented, not what it does.
• Plant part — whether the label states “root,” “root and leaf,” or another plant-part basis. Where documented, record it as an attributed disclosure fact. This article does not invent plant-part data and does not treat a plant-part basis as a quality verdict.
• Extract amount per serving — the declared ashwagandha extract amount, usually in milligrams (mg). Keep the unit consistent across products, and compare the amount alongside the named extract and any standardization.
• Withanolide standardization / disclosure — whether the label states a withanolide percentage or other standardization. Where stated, record it as an attributed disclosure fact. This article does not invent withanolide percentages and does not treat a higher percentage as automatically better.
• Serving size — the number of capsules, tablets, or scoops that the listed amounts refer to. Two products can declare the same extract amount while using different serving sizes.
• Additional ingredients — fillers, binders, capsule shell materials, or other active ingredients (such as other herbs or compounds marketed for stress or sleep). A combination product is a different formulation, not a stronger version of ashwagandha alone.
• Manufacturer transparency — a named manufacturer and traceable sourcing. Products that disclose more are easier to compare; products that disclose less are reported as such, not ranked against them.
• Testing / documentation — whether the product reports independent third-party testing, a named lab, or certifications. Recorded as attributed, never silently upgraded. A manufacturer or retailer claim is not the same as independent verification.

Where a label lists ashwagandha only inside a proprietary blend, the individual amount is not visible — that is a disclosure gap to note rather than a fact to compare. To inspect a specific label field by field, use the Analyze a Label tool.

“Clinically studied,” “full-spectrum,” “standardized,” “high-potency,” and “adaptogen” are not independently defined or regulated claims. They describe how a product is marketed, not what it is demonstrated to do. Use the same neutral framework for a KSM-66 product and a Sensoril product:

• Declared facts first — the named extract, the declared plant part, the extract amount per serving, any withanolide standardization, and the serving size. These are the fields that make two products comparable.
• Documentation over language — an extract claim backed by a cited study, a named lab, or independent testing is a stronger disclosure fact than unsupported marketing language on the front of the label.
• Keep preparation-specific evidence separate — if a product cites a study, note which preparation the study examined. Do not transfer findings from one extract to another.
• Record claims as attributed — where a product cites a specific study or named test, record it as an attributed disclosure fact, not as a quality ranking.
• Price per serving — compare cost per serving (and, where the declared information supports it, cost per comparable amount of extract). HerbParlor’s VitaValue™ places price next to a comparable quantity where the declared information supports a calculation, and reports an honest “unavailable” or “needs review” status where it does not.

Place products side by side in the ashwagandha comparison view, and use the Supplement Value Calculator to see standardized value where supported.

Run through this checklist for each product — KSM-66, Sensoril, or any other ashwagandha extract — before you compare them side by side. It keeps both preparations on the same scale and surfaces the gaps that make a comparison unreliable.

KSM-66 and Sensoril are different branded ashwagandha extracts with different documented specifications — most notably a root-only versus a root-and-leaf basis. A different specification can produce different research results, but a difference in specification is not the same as a demonstrated superiority for any health outcome. Neither extract is universally superior, and no ashwagandha product is established as a treatment for anxiety, sleep, stress, testosterone, fertility, athletic performance, or any condition.

Compare the named extract, the declared plant part, the extract amount per serving, any withanolide standardization, the serving size, the documented testing, and the manufacturer transparency — and read any cited study as preparation-specific rather than as a promise that applies to every ashwagandha product. That is the difference HerbParlor is built to make visible: it teaches you how to evaluate a product rather than telling you what to buy.

Once you can read a KSM-66 or Sensoril label for what it does and does not declare, HerbParlor’s comparison and analysis tools let you apply that literacy directly.

More HerbParlor reading that pairs with this guide:

• Ashwagandha decision hub — the full category gateway.
• Evidence Checker — separate attributed claims from documented support.
• Dose Analyzer — compare declared amounts and serving sizes across products.
• Transparency Checker — record what a label does and does not declare.
• Compare Supplements — place records from any category next to each other.